English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

3-(2-Deoxy-β-d -erythro -pentofuranosyl)pyrimido[1,2-α]purin-10(3H )-one (M1 dG) is a DNA adduct arising from the reaction of 2-deoxyguanosine with the lipid peroxidation product, malondialdehyde, or the DNA peroxidation product, base propenal. M1 dG is mutagenic in bacteria and mammalian cells and is present in the genomic DNA of healthy human beings. It is also detectable, albeit at low levels, in the urine of healthy individuals, which may make it a useful biomarker of DNA damage linked to oxidative stress. We investigated the possibility that the low urinary levels of M1 dG reflect metabolic conversion to derivatives. M1 dG was rapidly removed from plasma (t 1/2 = 10 min) after i.v. administration to rats. A single urinary metabolite was detected that was identified as 6-oxo-M1 dG by MS, NMR spectroscopy, and independent chemical synthesis. 6-Oxo-M1 dG was generatedin vitro by incubation of M1 dG with rat liver cytosols, and studies with inhibitors suggested that xanthine oxidase and aldehyde oxidase are involved in the oxidative metabolism. M1 dG also was metabolized by three separate human liver cytosol preparations, indicating 6-oxo-M1 dG is a likely metabolite in humans. This represents a report of the oxidative metabolism of an endogenous DNA adduct and raises the possibility that other endogenous DNA adducts are metabolized by oxidative pathways. 6-Oxo-M1 dG may be a useful biomarker of endogenous DNA damage associated with inflammation, oxidative stress, and certain types of cancer chemotherapy.

In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M 1 dG

In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M ₁ dG